AKT1 and Alzheimer disease: Cui-Zhu Yang and colleagues found that Astragaloside enhances cognitive function in APP/PS1 AD mouse models by activating the PI3K/AKT pathway, reducing hippocampal neuronal damage, and alleviating Aβ pathology (Yang et al., 2023).